Press Releases Verona Pharma plc

Equities

VRNA

US9250501064

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
14.75 ^USD	-0.87%		-6.35%	-25.80%

May. 09	Verona Pharma Signs Financing Agreements for Up to $650 Million	MT
May. 09	Verona Pharma Shares Decline After Q1 Loss Widens	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 09	AQ
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	May. 09	AQ
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024	May. 02	AQ
Verona Pharma : AGM 2024 Results	Apr. 26	PU
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update	Apr. 25	AQ
Verona Pharma : Notice and Proxy Statement AGM 2024	Mar. 21	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	Mar. 21	PU
Verona Pharma : Notice and Proxy Statement AGM 2024	Mar. 19	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	Mar. 19	PU
Andrew Fisher Joins Verona Pharma as General Counsel	Mar. 04	AQ
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Feb. 29	AQ
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	Feb. 15	AQ
Michael Austwick Joins Verona Pharma as Non-Executive Director	Feb. 01	AQ
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital	Jan. 02	AQ
Verona Pharma : Change in Certifying Accountants - Form 8-K	Dec. 18	PU
Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award	Nov. 17	AQ
Verona Pharma Announces November 2023 Investor Conference Participation	Nov. 08	AQ
Verona Pharma : VRNA Investor Presentation November 2023	Nov. 06	PU
Verona Pharma : VRNA Presentation November 2023	Nov. 02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Verona Pharma plc

Equities

VRNA

US9250501064

Press Releases

Filters